Drugs / [18F]-fluoromannitol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07110519 | Sep 2025 → Dec 2026 expected | — | St. Jude Children's Research Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]-fluoromannitol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07110519 ↗ |
| Modality | Diagnostic / imaging agent | “radiotracer for use with PET scan imaging” NCT07110519 ↗ |
| Route | Intravenous | “administration of intravenous \[18F\]-fluoromannitol as a radiotracer” NCT07110519 ↗ |